Results 201 to 210 of about 94,270 (218)

Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD

Cancer Cell, 2022
Chi Ma, Laurence P Diggs, John C Mcvey
exaly  

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment

International Journal of Molecular Sciences, 2022
Xunzhe Yin, Zuojia Liu
exaly  

Emerging role of aging in the progression of NAFLD to HCC

Ageing Research Reviews, 2023
Yingting Zhang, Ming He
exaly  

Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis

Clinical Gastroenterology and Hepatology, 2023
Cheng Han Ng, Clarissa Elysia Fu, Rebecca Wenling Zeng   +2 more
exaly  

Dysregulated lipid metabolism links NAFLD to cardiovascular disease

Molecular Metabolism, 2020
Audrey Deprince, Joel T Haas, Bart Staels   +2 more
exaly  

Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD

Clinical Gastroenterology and Hepatology, 2021
Vy H Nguyen, Michael H Le, Ramsey Cheung   +2 more
exaly  

Epidemiology and risk-stratification of NAFLD-associated HCC

Journal of Hepatology, 2021
George N Ioannou
exaly  

NAFLD and cardiovascular diseases: a clinical review

Clinical Research in Cardiology, 2020
Philipp Kasper, Anna Martin, Sonja Lang   +2 more
exaly  

Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka

Hepatology International, 2018
Madunil Anuk Niriella, A Kasturiratne, Arunasalam Pathmeswaran   +2 more
exaly  

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

Diabetologia, 2012
Giovanni Musso, Roberto Gambino, Cassader M   +2 more
exaly